<unk>  is a naturally occurring neurosteroid which is made in the body from the hormone progesterone. As a medication,<unk>  is referred to as brexanolone, sold under the brand name Zulresso, and used to treat postpartum depression. It is used by injection into a vein over a 60-hour period under medical supervision. Side effects of brexanolone may include sedation, sleepiness, dry mouth, hot flashes, and loss of consciousness. It is a neurosteroid and acts as a positive<unk> steric modulator of the GABAA receptor, the major biological target of the inhibitory neurotransmitter γ-aminobutyric acid (GABA). Brexanolone was<unk> proved for medical use in the United States in 2019. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication. The long administration time, as well as the cost for a one-time treatment, have raised concerns about accessibility for many women.
Allopregnanolone
Vinyltestosterone
Pregnanolone
Ethinylestradiol sulfonate
Estradiol enantate
Hydroxyprogesterone acetate
Methandriol propionate
Ethinylestradiol